Humacyte Total Current Liabilities

Humacyte (HUMA) currently reports a total current liabilities of $15M as of June 2026. That compares with $21M in the prior-year period — down 29.1% year over year. Use the charts on this page to explore Humacyte's total current liabilities history and peer comparisons.

Humacyte's total current liabilities decreased from $21M to $15M — a 29.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Humacyte reported $15M in total current liabilities as of June 2026. That compares with $21M in the prior-year period — down 29.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Humacyte, and consider following HUMA for alerts when major investors trade the stock.

Humacyte is classified in the Healthcare sector. On total current liabilities, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HUMA with unrelated industries.